Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9223783 | Annales de Dermatologie et de Vénéréologie | 2005 | 16 Pages |
Abstract
Encouraging good results were the subject of cases report, but lacking clinical trial, predicting probably administration of etanercept in others indications in future. TNF alpha is a proinflammatory cytokine and plays an important role in the physiopathology of large inflammatory diseases. Logically, in future, we should increased prescription of biotherapy, particularly anti-TNF alpha. We have to mind short or mild-term adverse events, widely described in the literature, but long-term side effects remained unknown. Moreover, these biotherapic agents have a high cost and should be estimate.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
A. Sparsa,